World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
48806
World Ranking
7240
National Ranking
213

Michael R. McClung publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael R. McClung sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 386 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael R. McClung D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. McClung sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2020 - Olof Johnell Science Award, International Osteoporosis Foundation
  • 1963 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Michael R. McClung is affiliated with the Australian Catholic University in Australia and has focused their research primarily in the field of Medicine, with a specialization in Orthopedics and Sports Medicine. Their body of work extensively covers bone health and osteoporosis research, bone metabolism and diseases, and related treatment methodologies.

Their recent publications include:

  • American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update (2020), published in Endocrine Practice
  • American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis- 2020 Update Executive Summary (2020), published in Endocrine Practice
  • Skeletal responses to romosozumab after 12 months of denosumab (2021), published in JBMR Plus
  • Hormones and Aging: An Endocrine Society Scientific Statement (2023), published in The Journal of Clinical Endocrinology & Metabolism
  • A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab (2020), published in Osteoporosis International

Frequently collaborating with other researchers, McClung's coauthors include:

  • E. Michael Lewiecki
  • Eugène McCloskey
  • Mary Bouxsein
  • Serge Ferrari
  • Felicia Cosman

McClung has published numerous papers in the following venues:

  • Journal of Bone and Mineral Research
  • Osteoporosis International
  • Journal of Clinical Densitometry
  • Menopause The Journal of The North American Menopause Society
  • Endocrine Practice

Their research topics span:

  • Bone health and osteoporosis research
  • Bone health and treatments
  • Bone Metabolism and Diseases
  • Hip and Femur Fractures
  • Endometriosis Research and Treatment
  • Vitamin D Research Studies
  • Bone fractures and treatments

Major fields of study include Medicine with a concentration in:

  • Orthopedics and Sports Medicine
  • Oncology
  • Molecular Biology
  • Surgery
  • Reproductive Medicine

McClung has been recognized with awards such as the Olof Johnell Science Award from the International Osteoporosis Foundation in 2020, and was made a Fellow of the American Association for the Advancement of Science (AAAS) in 1963.

Best Publications

  • Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis

    Steven R. Cummings;Javier San Martin;Michael R. Mcclung;Ethel S. Siris

  • Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

    Michael R. McClung;Piet Geusens;Paul D. Miller;Hartmut Zippel

  • Denosumab in postmenopausal women with low bone mineral density

    Michael R. McClung;E. Michael Lewiecki;Stanley B. Cohen;Michael A. Bolognese

  • Primer on the metabolic bone diseases and disorders of mineral metabolism

    John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston

  • American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2016

    Pauline M. Camacho;Steven M. Petak;Neil Binkley;Dima L. Diab

  • Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

    Samuel Vasikaran;Samuel Vasikaran;Richard Eastell;O. Bruyere;A. J. Foldes

  • Romosozumab in Postmenopausal Women with Low Bone Mineral Density

    Michael R. McClung;Andreas Grauer;Steven Boonen;Michael A. Bolognese

  • The 2017 hormone therapy position statement of The North American Menopause Society.

    Jo Ann V. Pinkerton;Fernando Sánchez Aguirre;Jennifer Blake;Felicia Cosman

  • American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

    Stephen F. Hodgson;Nelson B. Watts;John P. Bilezikian;Bart L. Clarke

  • Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

    Anthony B. Hodsman;Douglas C. Bauer;David W. Dempster;Larry Dian

  • Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.

    Paul D. Miller;Michael A. Bolognese;E. Michael Lewiecki;Michael R. McClung

  • Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

    D. Hosking;C. E. D. Chilvers;C. Christiansen;P. Ravn

  • Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis

    T. Schnitzer;H. G. Bone;G. Crepaldi;S. Adami

  • Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension

    Steven R Cummings;Serge Livio Ferrari;Richard Eastell;Nigel Gilchrist

  • Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

    Pernille Ravn;G Cizza;N H Bjarnason;D Thompson

  • Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society

    B. Ettinger;S. T. Harris;D. Kendler;B. Kessel

  • Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

    Michael McClung;Steven T. Harris;Paul D. Miller;Douglas C. Bauer

  • American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

    Nelson Watts;John Bilezikian;Pauline Camacho;Susan Greenspan

  • Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling

    Charles H. Chesnut;Michael R. McClung;Kristine E. Ensrud;Norman H. Bell

  • Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.

    Clifford J Rosen;Marc C Hochberg;Sydney L Bonnick;Michael McClung

Frequent Co-Authors

Paul D. Miller
Paul D. Miller University of Colorado Anschutz Medical Campus
E. Michael Lewiecki
E. Michael Lewiecki University of New Mexico
Robert R. Recker
Robert R. Recker Creighton University
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Jacques P. Brown
Jacques P. Brown Université Laval
John A. Eisman
John A. Eisman Garvan Institute of Medical Research
John P. Bilezikian
John P. Bilezikian Columbia University
Richard Eastell
Richard Eastell University of Sheffield
Susan L. Greenspan
Susan L. Greenspan University of Pittsburgh
Steven R. Cummings
Steven R. Cummings University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While many students aspire to study medicine in the USA, there are a variety of healthcare career pathways you can pursue online. For those interested in pharmacy, enrolling in a pharmacy school online offers flexibility while preparing for a high-demand field.

If you’re drawn to healthcare administration or data, a him associate degree online can kickstart your career in managing patient information and medical records. This is a great entry point for those who want to work behind the scenes in medical organizations.

Another popular option is getting a medical billing and coding certification. The certification cost is relatively low and these programs prepare you for specialized roles that are essential to the smooth operation of healthcare practices.

For registered nurses aiming to advance, the cheapest online np programs allow you to earn a Nurse Practitioner degree with minimal financial burden. These online degrees open the door to expanded responsibilities and higher earning potential in clinical settings.

Best Scientists Citing Michael R. McClung

Trending Scientists

Recently Published Articles